Evidence-based Clinical Decision Support Systems for the prediction and detection of three disease states in critical care: A systematic literature review [version 2; peer review:...

by Goran Medic, Melodi Kosaner Kließ, Louis Atallah, Jochen Weichert, Saswat Panda, Maarten Postma, Amer EL-Kerdi
Published 2019-11-01

Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe

by Goran Medic, Daria Korchagina, Katherine Eve Young, Mondher Toumi, Maarten Jacobus Postma, Micheline Wille, Michiel Hemels
Published 2017-01-01

Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States...

by Teresa L Kauf, Vimalanand S. Prabhu, Goran Medic, Rebekah H. Borse, Benjamin Miller, Jennifer Gaultney, Shuvayu S. Sen, Anirban Basu
Published 2017-04-01

Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infection...

by Vimalanand S. Prabhu, Joseph S. Solomkin, Goran Medic, Jason Foo, Rebekah H. Borse, Teresa Kauf, Benjamin Miller, Shuvayu S. Sen, Anirban Basu
Published 2017-10-01